Survival Outcomes from CALGB 80803 (Alliance): A Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
- Citation:
- J Clin Oncol vol 36 (15_suppl) 4012-4012
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3407
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Karyn A. Goodman Nathan Hall Tanios Bekaii-Saab Fang-Shu Ou Erin Twohy Michael Meyers Daniel Boffa Kristen Ciombor Wendy Frankel Alan Venook Eileen O'Reilly David Ilson
- Networks:
- CA136, LAPS-CT018, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, NY021, TN008
- Study
- CALGB-80803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: